Correction: Expert Narrative Review of the Safety of Cladribine Tablets for the Management of Relapsing Multiple Sclerosis

Affiliations

• ¹ Department of Neurology, Clermont-Ferrand University Hospital, 58 Rue Montalembert, 63003, Clermont-Ferrand Cedex 1, France. pclavelou@chu-clermontferrand.fr.
• ² Department of Neurology, Nîmes University Hospital, Hopital Caremeau, Nîmes, France.
• ³ Department of Infectious and Tropical Diseases, Pitié-Salpêtrière Hospital, APHP, Sorbonne Université, INSERM 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique Paris, Paris, France.
• ⁴ Department of Neurology, Strasbourg University Hospital, Strasbourg, France.
• ⁵ Univ. Lille, Inserm U1172 LilNCog, CHU Lille, FHU Precise, Lille, France.
• ⁶ Global Medical Affairs Neurology and Immunology, Ares Trading SA (An affiliate of Merck KGaA, Darmstadt, Germany), Eysins, Switzerland.
• ⁷ Neurology Department, Medical Affairs (An affiliate of Merck KGaA, Darmstadt, Germany), Merck Santé, Lyon, France.
• ⁸ Department of Neurology, Caen University Hospital, Caen, France.